載入...
Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering
Although chimeric antigen receptor (CAR)-engineered T cell therapy has achieved encouraging clinical trial results for treating hematological cancers, further optimization can likely expand this therapeutic success to more patients and other cancer types. Most CAR constructs used in clinical trials...
Na minha lista:
| 發表在: | Mol Ther |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Gene & Cell Therapy
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5675441/ https://ncbi.nlm.nih.gov/pubmed/28784559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2017.07.009 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|